Insurance Denied Your Gel Injection? How to Appeal and Get Covered

Q: How long do I have to appeal a gel injection denial?

For Original Medicare, you have 120 days from the date on your Medicare Summary Notice to file a redetermination (Level 1 appeal). For Medicare Advantage plans, the deadline is typically 60 days. Private insurance deadlines vary by plan but are usually between 30 and 180 days. Check your denial letter for the exact deadline -- this is the single most important date to know.

Key Takeaways

Over 80% of appealed prior authorization denials are overturned when patients and doctors provide complete documentation
The most common reasons for denial are missing prior authorization, incomplete step therapy documentation, and incorrect diagnosis codes
Medicare beneficiaries have five levels of appeal and 120 days to file their first appeal after receiving a denial notice
Private insurance patients have the right to an external independent review under the Affordable Care Act
A strong physician letter of medical necessity, along with imaging and treatment history, is the single most important piece of your appeal
Many denials happen due to administrative errors, not because the treatment is inappropriate for you

Getting a denial letter from your insurance company can feel like a punch to the gut, especially when you’re dealing with knee pain that limits your daily life. You and your doctor agreed that gel injections (hyaluronic acid viscosupplementation) could help, and now your insurance is saying no.

Here is the good news: a denial is not the final answer. Data from the Centers for Medicare & Medicaid Services shows that the majority of prior authorization denials are overturned on appeal. The problem is that fewer than 12% of patients actually file an appeal. Those who do fight back have a strong chance of getting their treatment covered.

This guide walks you through every step of the appeal process, whether you have Medicare or private insurance, so you can advocate for the treatment you need.

Why Gel Injections Get Denied

Understanding the reason behind your denial is the first step toward overturning it. Insurance companies deny viscosupplementation claims for five main reasons.

1. Missing or Incomplete Prior Authorization

This is the most common and most preventable reason for denials. Many insurance plans require your doctor to get approval before administering gel injections. If the injection happens without that prior approval, the claim will almost certainly be denied.

How to avoid this: Always confirm with your insurance company and your doctor’s office that prior authorization has been obtained and approved in writing before your procedure date. Learn more in our prior authorization guide.

2. Step Therapy Requirements Not Met

Most insurers require proof that you tried and failed less expensive treatments before they will approve gel injections. This is called “step therapy” or “fail-first” protocol. Typical requirements include:

Over-the-counter pain relievers (acetaminophen, NSAIDs) for at least 4-6 weeks
Physical therapy or a structured exercise program
Lifestyle modifications such as weight management
At least one cortisone injection

If your medical records do not clearly document these prior attempts and their failure, your claim may be denied even when you have actually tried these treatments.

3. Lack of Medical Necessity Documentation

Your insurer needs evidence that gel injections are medically appropriate for your specific case. Denials for “lack of medical necessity” usually mean the documentation submitted did not include:

X-ray or MRI results confirming osteoarthritis
Functional assessment scores (such as WOMAC or Knee Society Score)
A clear description of how knee pain limits your daily activities
An explanation of why other treatments were insufficient

4. Incorrect Diagnosis or Procedure Codes

Billing errors account for a surprising number of denials. The ICD-10 diagnosis code on your claim must match a covered indication. For knee osteoarthritis, the correct codes include:

ICD-10 Code	Description
M17.0	Bilateral primary osteoarthritis of knee
M17.11	Primary osteoarthritis, right knee
M17.12	Primary osteoarthritis, left knee
M17.9	Osteoarthritis of knee, unspecified

The procedure should be billed with CPT code 20610 (joint injection without ultrasound guidance) or 20611 (with ultrasound guidance), plus the appropriate J-code for the specific HA product used.

If the claim was submitted with a non-covered diagnosis code, such as a general joint pain code instead of a specific osteoarthritis code, the fix may be as simple as having your doctor’s office resubmit with the correct code.

5. Policy Exclusion or Non-Covered Benefit

Some private insurance plans explicitly exclude viscosupplementation from coverage, often citing older clinical guidelines. Approximately 17 major insurers covering roughly 64 million Americans do not cover hyaluronic acid injections as a standard benefit. If this is your situation, your appeal strategy will need to focus on demonstrating that current evidence supports the treatment and that multiple respected medical organizations now recommend it for appropriate patients. Read our detailed breakdown of why some plans don’t cover gel injections.

Understanding Your Denial Letter

When you receive a denial letter, don’t panic. Instead, read it carefully and look for these critical pieces of information:

What to Look for in Your Denial Letter

The specific reason for denial — Is it medical necessity? Step therapy? Prior authorization? A coding error? The reason determines your appeal strategy.

Your appeal deadline — Medicare gives you 120 days from the date on the Medicare Summary Notice. Private insurers typically allow 30-180 days. Missing this deadline can forfeit your right to appeal.

The clinical criteria used — The letter should reference the specific coverage policy or medical guidelines the reviewer used to make their decision.

Instructions for how to appeal — Every denial letter must include information about your appeal rights and how to submit an appeal.

The reviewer’s credentials — Note whether the denial was made by a nurse reviewer, a medical director, or an automated system. This affects how you structure your appeal.

Keep the original denial letter and make copies. You will reference it throughout the appeal process.

Medicare Appeal Process: Five Levels

If you have Original Medicare (Part A and Part B) or a Medicare Advantage plan, you have the right to appeal through a structured five-level process. Each level has its own timeline and review body. You do not need a lawyer for the early levels.

For more on how Medicare covers gel injections in the first place, see our Medicare Part B coverage guide and Medicare Advantage guide.

Level 1: Redetermination

Who reviews it: Your Medicare Administrative Contractor (MAC) for Original Medicare, or your Medicare Advantage plan

Deadline to file: 120 days from the date on your Medicare Summary Notice

Decision timeline: 60 days for Original Medicare claims; 30 days for Medicare Advantage pre-service denials

This is your first and most important appeal. Submit a written request along with all supporting documentation. For Medicare Advantage plans, over 80% of appealed prior authorization denials are partially or fully overturned at this level.

What to include: Your denial letter, a physician letter of medical necessity, imaging results, conservative treatment records, and any relevant clinical guidelines supporting viscosupplementation.

Level 2: Reconsideration by a Qualified Independent Contractor (QIC)

Who reviews it: An independent organization that was not involved in the original decision

Deadline to file: 180 days from the Level 1 decision

Decision timeline: 60 days

If your redetermination is denied, this is your next step. A fresh set of eyes reviews your case. You can submit additional documentation at this stage.

Level 3: Administrative Law Judge (ALJ) Hearing

Who reviews it: An Administrative Law Judge at the Office of Medicare Hearings and Appeals (OMHA)

Deadline to file: 60 days from the Level 2 decision

Minimum amount in controversy: $200 for 2026

This level involves a hearing, often conducted by phone or video. You or your representative can present your case directly to a judge. Approximately 42-51% of Medicare Advantage cases that reach this level receive a fully or partially favorable decision.

Level 4: Medicare Appeals Council Review

Who reviews it: The Departmental Appeals Board within HHS

Deadline to file: 60 days from the ALJ decision

This is a paper review. The Appeals Council can decide to review the ALJ’s decision or decline to hear the case.

Level 5: Federal District Court

Minimum amount in controversy: $1,840 for 2026

Deadline to file: 60 days from the Appeals Council decision

This is the final level and involves filing a civil action in federal court. Very few cases reach this point. For a single course of gel injections, this level typically does not apply because the amount in controversy may not meet the threshold.

The Encouraging Reality About Appeals

Most successful Medicare appeals are resolved at Level 1 or Level 2. You generally do not need to go further than that. The key is submitting strong documentation with your first appeal.

Remember: Only about 11-12% of denied claims are ever appealed, yet the success rate is remarkably high for those who do. Do not let the process intimidate you into giving up.

Private Insurance Appeal Process

If you have employer-sponsored insurance, a marketplace plan, or another private health plan, your appeal process typically has two stages. Your rights are protected under the Affordable Care Act.

Stage 1: Internal Appeal

When your private insurer denies coverage for gel injections, you have the right to ask them to conduct a full and fair review of their decision. This is called an internal appeal.

Key details:

You typically have 30 to 180 days from the denial date to file (check your denial letter for the exact deadline)
The review must be conducted by someone who was not involved in the original denial
The reviewer should be a healthcare professional with expertise in the relevant clinical area
You can submit new evidence, including updated medical records, additional clinical studies, and your doctor’s letter of medical necessity
The insurer must make a decision within 30 days for pre-service denials or 60 days for post-service claims

Stage 2: External Independent Review

If your internal appeal is denied, you have the right under federal law to request an external review by an independent third party that has no connection to your insurance company.

Key details:

You must request external review within 4 months of receiving your internal appeal denial
The review is conducted by an independent review organization (IRO) certified by your state
The IRO’s decision is binding on the insurer — if they rule in your favor, your insurance company must cover the treatment
There is generally no cost to you for the external review process
The decision is typically made within 45 days for standard reviews

Your Rights Under the Affordable Care Act

Right to appeal: Every health plan must provide at least one level of internal appeal and access to external review.

Right to information: Your insurer must explain the reason for the denial and the clinical criteria they applied.

Right to representation: You can have someone (a family member, friend, or patient advocate) file the appeal on your behalf.

Right to expedited review: If your health is at risk from waiting, you can request an expedited appeal that must be resolved within 72 hours.

What Documentation You Need for Your Appeal

A strong appeal is built on thorough documentation. Gather the following before you file.

Appeal Documentation Checklist

Copy of your denial letter with the specific reason for denial highlighted

Imaging results — X-rays showing joint space narrowing, bone spurs, or other signs of osteoarthritis (Kellgren-Lawrence Grade 2 or higher strengthens your case)

Conservative treatment history — Dates, duration, and documented outcomes for every treatment you tried (NSAIDs, physical therapy, cortisone, etc.)

Functional assessment scores — WOMAC, Knee Society Score, or VAS pain scores showing the impact on your daily life

Physician letter of medical necessity — A detailed letter from your treating physician (see framework below)

Current clinical guidelines — References to OARSI (2019), VA/DoD (2020), and ACR/Arthritis Foundation (2019) guidelines that support HA use in appropriate patients

Peer-reviewed studies — Published research supporting viscosupplementation effectiveness for your specific situation

Your own written statement — A personal description of how knee pain affects your ability to walk, climb stairs, sleep, work, or care for yourself

For a deeper look at the cost considerations, see our gel injection cost guide.

Sample Appeal Letter Framework

Your physician’s letter of medical necessity is the cornerstone of your appeal. While every case is different, an effective appeal letter generally covers the following elements. Share this framework with your doctor.

Elements of an Effective Appeal Letter

1. Patient identification and claim details Include your full name, date of birth, insurance ID number, claim or authorization number, and the date of the denial.

2. Diagnosis with supporting evidence State the specific ICD-10 diagnosis code (e.g., M17.11 for primary osteoarthritis, right knee) and reference imaging findings that confirm the diagnosis, such as Kellgren-Lawrence grade and specific findings on X-ray.

3. Conservative treatment timeline Provide a chronological summary of every treatment attempted, including specific dates, durations, and documented outcomes. Note any adverse effects from medications, such as GI issues from long-term NSAID use.

4. Functional impact Describe how the condition affects the patient’s activities of daily living using objective measures (WOMAC score, walking distance, stair-climbing ability) alongside the patient’s own account.

5. Medical necessity argument Explain why viscosupplementation is the appropriate next treatment step, referencing current clinical guidelines. Cite specific organizations (OARSI, VA/DoD, ACR) that support HA use and note that the AAOS softened its position from “strongly against” to “not for routine use” in 2021.

6. Risk-benefit analysis Address alternatives and their limitations. For instance, continued NSAID use carries cardiovascular and gastrointestinal risks, cortisone injections may accelerate cartilage degradation with repeated use, and the patient may not be a candidate for or wishes to delay knee replacement surgery.

7. Request for reconsideration Clearly state that you are requesting the denial be overturned and the treatment be approved.

How to Prevent Denials in the First Place

The best appeal is one you never have to file. Work with your doctor’s office to build a strong case from the beginning.

Before Your Appointment

Call your insurance company and ask specifically about coverage for viscosupplementation. Ask for the coverage criteria in writing.
Verify prior authorization requirements. Ask whether your plan requires prior authorization and how long the process takes.
Confirm the correct codes. Ask what ICD-10 diagnosis codes and CPT procedure codes are required for coverage.

During Treatment Planning

Document every failed treatment in your medical record with dates, duration, and outcomes.
Get imaging done early. X-rays confirming osteoarthritis are required by virtually every insurer. Make sure your imaging is recent (within 6-12 months).
Complete functional assessments. Ask your doctor to record WOMAC or similar standardized pain and function scores at each visit.

When Filing for Prior Authorization

Submit complete records the first time. Incomplete submissions are the number one cause of preventable denials.
Include the letter of medical necessity with the initial prior authorization request, not just after a denial.
Follow up within 5-7 business days if you have not received a response. Do not assume silence means approval.
Get the approval in writing with the specific procedure codes, number of injections approved, and the approval expiration date.

For a complete walkthrough of the prior authorization process, see our prior authorization guide.

When to Get Help

If your appeal feels overwhelming, or if you have been denied at multiple levels, there are people and organizations that can help — often at no cost to you.

Patient Advocates

Many hospitals and medical practices have patient advocates or financial counselors who can help you navigate the appeal process. Ask your doctor’s office if this service is available.

State Insurance Department

Every state has an insurance department or commissioner’s office that handles consumer complaints about health insurance. They can:

Help you understand your rights
Intervene on your behalf with your insurer
Investigate whether your insurer is following state regulations

Medicare Ombudsman

If you have Medicare, the Medicare Beneficiary Ombudsman can help you with complaints, grievances, and information requests. Contact 1-800-MEDICARE (1-800-633-4227) for assistance.

State Health Insurance Assistance Program (SHIP)

SHIP counselors provide free, personalized assistance to Medicare beneficiaries. They can help you understand your coverage, file appeals, and navigate the Medicare system. Find your local SHIP program at shiphelp.org.

Legal Aid Organizations

If you have been denied at multiple levels and believe your rights are being violated, legal aid organizations may be able to help with higher-level appeals at no cost, depending on your income and situation.

Frequently Asked Questions

How long do I have to appeal a gel injection denial?

For Original Medicare, you have 120 days from the date on your Medicare Summary Notice to file a redetermination (Level 1 appeal). For Medicare Advantage plans, the deadline is typically 60 days. Private insurance deadlines vary by plan but are usually between 30 and 180 days. Check your denial letter for the exact deadline — this is the single most important date to know.

What are my chances of winning an appeal?

Your chances are better than you might think. According to CMS data, over 80% of Medicare Advantage prior authorization denials that are appealed are partially or fully overturned. For Original Medicare, the overturn rate varies by service type. The key factor in success is submitting thorough, well-organized documentation with your appeal.

Can I receive treatment while my appeal is pending?

In most cases, you would need to pay out of pocket for treatment while an appeal is pending and then seek reimbursement if the appeal is successful. However, if you have a Medicare Advantage plan and were already receiving treatment that was subsequently denied, you may be able to request continuation of benefits during the appeal under certain circumstances. Ask your plan for details.

What if my insurance plan explicitly excludes gel injections?

This is the most challenging situation. You can still appeal by arguing that the exclusion is based on outdated clinical evidence and that multiple current guidelines support HA use. Reference the OARSI 2019 conditional recommendation, VA/DoD 2020 conditional recommendation, and the ACR/Arthritis Foundation 2019 conditional stance. For external reviews, the independent reviewer is required to consider current medical evidence, not just the insurer’s coverage policy.

Does my doctor need to file the appeal, or can I do it myself?

You can file an appeal yourself, but having your doctor actively involved significantly strengthens your case. In practice, the most effective approach is a team effort: your doctor provides the medical documentation and letter of medical necessity, while you submit the appeal with a personal statement describing how the condition affects your life. You can also authorize someone else — a family member, friend, or patient advocate — to file on your behalf.

What are the costs of filing an appeal?

Filing an appeal is free. There are no fees charged by Medicare, your insurance company, or external review organizations for processing your appeal. The only potential cost is your time in gathering documentation and writing your statement. If you choose to hire a lawyer for higher-level appeals, there may be legal fees, but this is rarely necessary for gel injection denials.

Stay ahead of joint pain

Get weekly insights on joint health and pain relief delivered to your inbox.

Join 10,000+ readers. No spam.

Prior Authorization for Gel Injections: A Guide — Learn how to navigate the pre-approval process
Why 30% of Plans Don’t Cover Gel Injections — Understand the coverage gap
Medicare Part B Coverage for Joint Treatments — What Original Medicare covers
Medicare Advantage Coverage Guide — How MA plans handle gel injections
Gel Injection Cost Guide — What to expect financially
Hyaluronic Acid Injections Overview — Treatment details and evidence
Insurance and Prior Authorization FAQs — Quick answers to common questions

References

Centers for Medicare & Medicaid Services. “Medicare Claims Processing Manual, Chapter 32 - Billing Requirements for Special Services.” CMS.gov. Accessed March 2026.
Kaiser Family Foundation. “Medicare Advantage Insurers Made Nearly 53 Million Prior Authorization Determinations in 2024.” KFF.org. 2025.
American Medical Association. “Over 80% of Prior Auth Appeals Succeed — Why Aren’t There More?” AMA-assn.org. 2024.
CMS Medicare Coverage Database. “LCD L39260 - Hyaluronic Acid Injections for Knee Osteoarthritis.” CMS.gov. Accessed March 2026.
CMS Medicare Coverage Database. “Billing Article A59030 - Hyaluronic Acid Knee Injections.” CMS.gov. Accessed March 2026.
Osteoarthritis Research Society International (OARSI). “OARSI Guidelines for Non-Surgical Management of Knee, Hip, and Polyarticular Osteoarthritis.” Osteoarthritis and Cartilage. 2019;27(11):1578-1589.
Department of Veterans Affairs/Department of Defense. “VA/DoD Clinical Practice Guideline for the Non-Surgical Management of Hip and Knee Osteoarthritis.” Version 2.0. 2020.
Kolasinski SL, et al. “2019 American College of Rheumatology/Arthritis Foundation Guideline for the Management of Osteoarthritis of the Hand, Hip, and Knee.” Arthritis Care & Research. 2020;72(2):149-162.
U.S. Department of Health and Human Services, Office of Medicare Hearings and Appeals. “Current Workload Decision Statistics.” HHS.gov. Accessed March 2026.
Patient Advocate Foundation. “Insurance Appeals and Denials: Understanding Your Rights.” PatientAdvocate.org. 2025.